E
Edgewise Therapeutics D
D
EWTX
32.290
USD
0.27
(0.84%)
Market Closed
Volume
13,931
EPS
-1
Div Yield
-
P/E
-22
Market Cap
3,057,492,214
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Edgewise Therapeutics
Sector: Healthcare
Industry: Biotechnology
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.